A detailed history of Black Rock Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,871,496 shares of LGND stock, worth $327 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,871,496
Previous 2,868,270 0.11%
Holding current value
$327 Million
Previous $210 Million 15.4%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$68.53 - $87.91 $221,077 - $283,597
3,226 Added 0.11%
2,871,496 $242 Million
Q1 2024

May 10, 2024

SELL
$68.64 - $89.2 $6.46 Million - $8.39 Million
-94,044 Reduced 3.17%
2,868,270 $210 Million
Q4 2023

Feb 13, 2024

BUY
$49.57 - $72.63 $6.01 Million - $8.8 Million
121,230 Added 4.27%
2,962,314 $212 Million
Q3 2023

Nov 13, 2023

SELL
$58.86 - $72.67 $3.83 Million - $4.73 Million
-65,075 Reduced 2.24%
2,841,084 $170 Million
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $4.69 Million - $5.35 Million
67,497 Added 2.38%
2,906,159 $210 Million
Q1 2023

May 12, 2023

BUY
$65.67 - $77.08 $3.21 Million - $3.77 Million
48,898 Added 1.75%
2,838,662 $209 Million
Q4 2022

Feb 13, 2023

BUY
$61.72 - $96.74 $7.66 Million - $12 Million
124,146 Added 4.66%
2,789,764 $186 Million
Q3 2022

Nov 14, 2022

SELL
$0.01 - $107.56 $392 - $4.22 Million
-39,229 Reduced 1.45%
2,665,618 $230 Million
Q2 2022

Aug 12, 2022

SELL
$74.52 - $117.06 $2.12 Million - $3.33 Million
-28,460 Reduced 1.04%
2,704,847 $241 Million
Q1 2022

May 12, 2022

SELL
$94.99 - $151.56 $902,499 - $1.44 Million
-9,501 Reduced 0.35%
2,733,307 $307 Million
Q4 2021

Feb 10, 2022

BUY
$127.69 - $165.85 $1.48 Million - $1.93 Million
11,614 Added 0.43%
2,742,808 $424 Million
Q3 2021

Nov 09, 2021

BUY
$102.33 - $144.73 $70.3 Million - $99.4 Million
686,816 Added 33.6%
2,731,194 $381 Million
Q2 2021

Aug 11, 2021

BUY
$113.03 - $155.64 $231 Million - $318 Million
2,044,378 New
2,044,378 $268 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.92B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.